64 reports

  • 3 Epidemiology
  • 2.1 RELATED REPORTS

Table ## lists the most common risk factors and comorbidities associated with PD. ##. ## RISK FACTORS AND COMORBIDITIES Table ##: Risk Factors and Comorbidities for PD Reviews on the epidemiology of PD discussed increasing age as being a strong risk factor for the disorder, hav

  • Psychotic Disorder
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • REFERENCES

Epidemiology and etiology.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Northern Europe
  • Western Europe

Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Psychotic Disorder
  • France
  • United States
  • World
  • Forecast

Global Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017 ##.

  • Psychotic Disorder
  • France
  • United States
  • World
  • Forecast
  • 2 Epidemiology
  • 7MM, 12-Month Diagnosed Prevalent Cases of Schizophrenia, Ages ≥13 Years, Both Sexes, N,

Epidemiology and Psychiatric Sciences; ##(##): ##-##.

  • Psychotic Disorder
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • Abbreviations and acronyms used in the report
  • REFERENCES

Tohoku J Exp Med. 2010; ##(##):##-## ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • North America
  • 5 Epidemiology
  • PARKINSON'S DISEASE: KEY METRICS IN THE 7MM

ET AL. (2016) ' EPIDEMIOLOGY OF PARKINSON' S DISEASE: A POPULATION-BASED STUDY IN PRIMARY CARE IN ITALY', NEUROEPIDEMIOLOGY, ##(##), PP. ##-##.

  • Psychotic Disorder
  • Forecast
  • Adamas Pharmaceuticals, Inc.
  • Impax Laboratories, Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Parkinson's Disease
  • CNS DISORDERS

Attention-Deficit Hyperactivity Disorder Table ##: Epidemiology of ADHD in Adults, 2017 Table ##: Epidemiology of ADHD in Children, 2017 Source: WHO Source: WHO The table below presents the forecast epidemiology of ADHD in adults across the ##MM through 2023.

  • Hospital
  • Psychotic Disorder
  • AstraZeneca PLC
  • Lilly Endowment Inc.
  • Pfizer Inc.

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017 ##.

  • Psychotic Disorder
  • Europe
  • France
  • Germany
  • Forecast

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017 ##.

  • Psychotic Disorder
  • Europe
  • France
  • Germany
  • Italy
  • EPIDEMIOLOGY - SCHIZOPHRENIA
  • Schizophrenia

Sun, Y., Gregersen, H., and Yuan, W. (2017) ' Chinese health system and clinical epidemiology', Clinical Epidemiology, ##:##-##. doi: ##. ##/ CLEP.

  • Psychotic Disorder
  • United States
  • World
  • Boehringer Ingelheim GmbH
  • Pfizer Inc.
  • EPIDEMIOLOGY - PARKINSON'S DISEASE

Overview of Stem Cells for Neurology and Epidemiology ## ##.

  • Cell Therapy
  • Psychotic Disorder
  • United States
  • Asterias
  • Neuralstem, Inc.
  • 4.4 EPIDEMIOLOGY FOR PARKINSON'S DISEASE
  • 8.1 BIBLIOGRAPHY

M. (2006) ' Epidemiology of Parkinson disease', Lancet Neurology, ##(##), pp. ##-##.

  • Mental Health
  • Psychotic Disorder
  • World
  • AbbVie Inc.
  • BioMedica Inc.

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Psychotic Disorder
  • France
  • Germany
  • United States
  • Market Shares

Parkinson' s Disease Phase ## Clinical Trials, 2016 ##.

  • Psychotic Disorder
  • France
  • Germany
  • United States
  • Market Shares
  • Epidemiology
  • 4 Epidemiology

EPIDEMIOLOGY AND PSYCHIATRIC SCIENCES; ##(##): ##-##.

  • Psychotic Disorder
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • MAY 21, 2018: CELL TYPES UNDERLYING SCHIZOPHRENIA IDENTIFIED

The study included more than ## ## adolescents.

  • Cancer
  • Psychotic Disorder
  • Sweden
  • Karolinska Institutet Holding
  • Takeda Pharmaceutical Company Limited

EPIDEMIOLOGY: PARKINSON’S DISEASE (Published on ## June 2018) ## OVERVIEW ## DISEASE BACKGROUND ## METHODOLOGY ## FORECAST ## BIBLIOGRAPHY ## APPENDIX ## MARKETED DRUGS: PARKINSON’S DISEASE (Published on ## June 2018) ## OVERVIEW ## PRODUCT OVERVIEW ## PRODUCT PROFILE: A

  • Mental Health
  • Psychotic Disorder
  • European Union
  • Japan
  • United States

Schizophrenia - Current and Future Players ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Catalyst ## ##. ## Related Reports ## ## Market Outlook ## ##. ## Global Markets ## ##. ##. ## Forecast ## ##. ##. ## Drivers and Barriers - Global Issues

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • World
  • Demand

EPIDEMIOLOGY: SCHIZOPHRENIA (Published on ## November 2017) ## OVERVIEW ## EXECUTIVE SUMMARY ## DISEASE BACKGROUND ## METHODOLOGY ## FORECAST ## EPIDEMIOLOGIST INSIGHT ## BIBLIOGRAPHY ## APPENDIX: ADDITIONAL SOURCES ## MARKETED DRUGS: SCHIZOPHRENIA (Published on ## March 2018) ##

  • Psychotic Disorder
  • European Union
  • Japan
  • United States
  • Demand

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Psychotic Disorder
  • France
  • Germany
  • Italy
  • Market Shares

Parkinson' s Disease Phase ## Clinical Trials, 2016 ##.

  • Psychotic Disorder
  • France
  • Germany
  • Italy
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • Japan
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • United States
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • United Kingdom
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • Italy
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • Germany
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • France
  • Forecast
  • Market Shares

Schizophrenia Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Psychotic Disorder
  • Spain
  • Forecast
  • Market Shares

Parkinson' s Disease Phase ## Clinical Trials, 2016 ##.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Japan
  • Market Shares